Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-20-038761

Executive VP, Head of R&D sold 7,158 shares at an average $75.04 ($537,123)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ho Tony W Executive VP, Head of R&D 2020-06-22 Sale −229 $70.14 $16,062 40,676 D
Ho Tony W Executive VP, Head of R&D 2020-06-23 Sale −6,929 $75.20 $521,061 33,747 D
Open-market sales · 7,158 sh · avg $75.04 · $537,123
Loading xslF345X03/doc4.xml…